MEIRAGTX HLDGS PLC's ticker is MGTX and the CUSIP is G59665102. A total of 76 filers reported holding MEIRAGTX HLDGS PLC in Q3 2023. The put-call ratio across all filers is 1.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $201,150 | +126409.4% | 29,933 | -2.6% | 0.00% | – |
| Q1 2023 | $159 | +114.9% | 30,738 | +171.7% | 0.00% | – |
| Q4 2022 | $74 | -100.0% | 11,315 | -80.7% | 0.00% | – |
| Q3 2022 | $492,000 | -33.9% | 58,545 | -40.4% | 0.00% | – |
| Q2 2022 | $744,000 | -35.8% | 98,288 | +17.6% | 0.00% | -100.0% |
| Q1 2022 | $1,158,000 | +100.3% | 83,607 | +108.6% | 0.00% | – |
| Q1 2021 | $578,000 | -58.6% | 40,073 | -56.6% | 0.00% | -100.0% |
| Q4 2020 | $1,397,000 | +778.6% | 92,283 | +625.3% | 0.00% | – |
| Q2 2020 | $159,000 | -90.3% | 12,724 | -84.4% | 0.00% | -100.0% |
| Q4 2019 | $1,637,000 | -49.9% | 81,747 | -60.1% | 0.00% | -60.0% |
| Q3 2019 | $3,269,000 | +149.4% | 204,966 | +320.3% | 0.01% | +150.0% |
| Q2 2019 | $1,311,000 | +620.3% | 48,768 | +362.2% | 0.00% | – |
| Q1 2019 | $182,000 | -80.3% | 10,551 | -86.9% | 0.00% | -100.0% |
| Q2 2018 | $923,000 | – | 80,568 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Johnson & Johnson Innovation - JJDC, Inc. | 2,898,550 | $38,957,000 | 21.20% |
| Prosight Management, LP | 568,348 | $7,639,000 | 3.57% |
| Perceptive Advisors | 6,433,277 | $86,463,000 | 2.25% |
| Orbimed Advisors | 3,582,320 | $48,146,000 | 0.81% |
| Parkman Healthcare Partners LLC | 125,000 | $1,680,000 | 0.78% |
| 683 Capital Management, LLC | 831,748 | $11,178,000 | 0.66% |
| Claraphi Advisory Network, LLC | 98,850 | $1,329,000 | 0.63% |
| Fort Sheridan Advisors LLC | 54,512 | $733,000 | 0.54% |
| Rhenman & Partners Asset Management AB | 246,307 | $3,310,000 | 0.46% |
| PA Capital LLC | 39,039 | $525,000 | 0.46% |